http://orcid.org/0000-0002-0895-7654
Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Eduard Brunet, Emili Vela, Luigi Melcarne, Laura-Patricia Llovet, Anna Puy, Montserrat Clèries, Caridad Pontes, Pilar García-Iglesias, Albert Villòria, Gilaad G. Kaplan & Xavier Calvet. (2022) Heterogeneity in pharmacological treatment and outcomes in Crohn’s disease patients in Catalonia: a population-based observational study. Annals of Medicine 54:1, pages 1255-1264.
Read now
Read now
Karoline Anisdahl, Sandre Svatun Lirhus, Asle W. Medhus, Bjørn Moum, Hans Olav Melberg & Marte Lie Høivik. (2021) First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study. Scandinavian Journal of Gastroenterology 56:10, pages 1163-1168.
Read now
Read now
Articles from other publishers (7)
Adnan Fayadh Sameer. (2023) Investigation of Crohn's Disease by Immunohistochemistry Technique in Iraqi Patients. Bionatura 8:2, pages 1-12.
Crossref
Crossref
Catherine Le Berre, Silvio Danese & Laurent Peyrin-Biroulet. (2023) Can we change the natural course of inflammatory bowel disease?. Therapeutic Advances in Gastroenterology 16, pages 175628482311631.
Crossref
Crossref
Catherine Le Berre, Amanda Ricciuto, Laurent Peyrin-Biroulet & Dan Turner. (2022) Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last. Gastroenterology 162:5, pages 1424-1438.
Crossref
Crossref
Lester Tsai, Christopher Ma, Parambir S. Dulai, Larry J. Prokop, Samuel Eisenstein, Sonia L. Ramamoorthy, Brian G. Feagan, Vipul Jairath, William J. Sandborn & Siddharth Singh. (2021) Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based Cohorts. Clinical Gastroenterology and Hepatology 19:10, pages 2031-2045.e11.
Crossref
Crossref
Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen & Hans Olav Melberg. (2021) Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study. Therapeutic Advances in Gastroenterology 14, pages 175628482110217.
Crossref
Crossref
Eduard Brunet, Emili Vela, Luigi Melcarne, Montserrat Clèries, Caridad Pontes, Laura Patricia Llovet, Pilar García-Iglesias, Marta Gallach, Albert Villòria, Mercedes Vergara & Xavier Calvet. (2020) Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery. Journal of Clinical Medicine 9:9, pages 2896.
Crossref
Crossref
Luca Di Martino, Abdullah Osme, Sarah Kossak-Gupta, Theresa T. Pizarro & Fabio Cominelli. (2019) TWEAK/Fn14 Is Overexpressed in Crohn’s Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways. Cellular and Molecular Gastroenterology and Hepatology 8:3, pages 427-446.
Crossref
Crossref